Evaluation of Bcl-2 as a marker for chronic kidney disease prediction in cats

Chronic kidney disease (CKD) is a frequent condition in elderly cats. Bcl-2 is linked to kidney disease through the processes of apoptosis and fibrosis. The purpose of this study is to examine Bcl-2 levels in CKD and clinically healthy age-matched cats in order to evaluate the relationship between B...

Full description

Bibliographic Details
Main Authors: Pattiya Pila, Phongsakorn Chuammitri, Prapas Patchanee, Kidsadagon Pringproa, Kakanang Piyarungsri
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Veterinary Science
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2022.1043848/full
_version_ 1797956974831206400
author Pattiya Pila
Phongsakorn Chuammitri
Phongsakorn Chuammitri
Prapas Patchanee
Kidsadagon Pringproa
Kakanang Piyarungsri
Kakanang Piyarungsri
author_facet Pattiya Pila
Phongsakorn Chuammitri
Phongsakorn Chuammitri
Prapas Patchanee
Kidsadagon Pringproa
Kakanang Piyarungsri
Kakanang Piyarungsri
author_sort Pattiya Pila
collection DOAJ
description Chronic kidney disease (CKD) is a frequent condition in elderly cats. Bcl-2 is linked to kidney disease through the processes of apoptosis and fibrosis. The purpose of this study is to examine Bcl-2 levels in CKD and clinically healthy age-matched cats in order to evaluate the relationship between Bcl-2 levels, signalment, and blood parameters in cats with CKD. The circulating levels of Bcl-2 were determined using an immunoassay in twenty-four CKD cats and eleven clinically healthy age-matched cats by the utilization of the general linear model (GLM), Pearson correlation, principal component analysis (PCA), ROC curves, the Cox hazard model, and Kaplan–Meier survival analysis. These were all conducted in order to explore Bcl-2 levels and their connection with other variables. The Bcl-2 immunohistochemical intensity was graded in each glomerulus and tubulointerstitium. McNemar's test was performed in order to compare the expression of Bcl-2 in the two renal tissue sites. The circulating Bcl-2 of CKD cats was significantly lower than those of clinically healthy age-matched cats (P = 0.034). The presence of circulating Bcl-2 (P < 0.01) and the severity of CKD (P = 0.02) were both linked with the survival time of cats with CKD. The area under the curve (AUC) of Bcl-2 for detection of CKD was 0.723. In cats, decreased circulating Bcl-2 was associated with increased blood BUN, creatinine levels, and CKD severity. Bcl-2 protein expression was reduced in the renal tissues of CKD cats as the disease progressed, resulting in a decrease in their survival time. This study demonstrated that Bcl-2 may be effective in diagnosing feline CKD.
first_indexed 2024-04-10T23:57:05Z
format Article
id doaj.art-b872fbe978414a2aaedc395aa180d7c1
institution Directory Open Access Journal
issn 2297-1769
language English
last_indexed 2024-04-10T23:57:05Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Veterinary Science
spelling doaj.art-b872fbe978414a2aaedc395aa180d7c12023-01-10T12:33:38ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692023-01-01910.3389/fvets.2022.10438481043848Evaluation of Bcl-2 as a marker for chronic kidney disease prediction in catsPattiya Pila0Phongsakorn Chuammitri1Phongsakorn Chuammitri2Prapas Patchanee3Kidsadagon Pringproa4Kakanang Piyarungsri5Kakanang Piyarungsri6Department of Companion Animal and Wildlife Clinic, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai, ThailandResearch Center of Producing and Development of Products and Innovations for Animal Health and Production, Chiang Mai University, Chiang Mai, ThailandDepartment of Veterinary Bioscience and Veterinary Public Health, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai, ThailandDepartment of Food Animal Clinic, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai, ThailandDepartment of Veterinary Bioscience and Veterinary Public Health, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai, ThailandDepartment of Companion Animal and Wildlife Clinic, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai, ThailandResearch Center of Producing and Development of Products and Innovations for Animal Health and Production, Chiang Mai University, Chiang Mai, ThailandChronic kidney disease (CKD) is a frequent condition in elderly cats. Bcl-2 is linked to kidney disease through the processes of apoptosis and fibrosis. The purpose of this study is to examine Bcl-2 levels in CKD and clinically healthy age-matched cats in order to evaluate the relationship between Bcl-2 levels, signalment, and blood parameters in cats with CKD. The circulating levels of Bcl-2 were determined using an immunoassay in twenty-four CKD cats and eleven clinically healthy age-matched cats by the utilization of the general linear model (GLM), Pearson correlation, principal component analysis (PCA), ROC curves, the Cox hazard model, and Kaplan–Meier survival analysis. These were all conducted in order to explore Bcl-2 levels and their connection with other variables. The Bcl-2 immunohistochemical intensity was graded in each glomerulus and tubulointerstitium. McNemar's test was performed in order to compare the expression of Bcl-2 in the two renal tissue sites. The circulating Bcl-2 of CKD cats was significantly lower than those of clinically healthy age-matched cats (P = 0.034). The presence of circulating Bcl-2 (P < 0.01) and the severity of CKD (P = 0.02) were both linked with the survival time of cats with CKD. The area under the curve (AUC) of Bcl-2 for detection of CKD was 0.723. In cats, decreased circulating Bcl-2 was associated with increased blood BUN, creatinine levels, and CKD severity. Bcl-2 protein expression was reduced in the renal tissues of CKD cats as the disease progressed, resulting in a decrease in their survival time. This study demonstrated that Bcl-2 may be effective in diagnosing feline CKD.https://www.frontiersin.org/articles/10.3389/fvets.2022.1043848/fullBcl-2biomarkercatchronic kidney diseaseprediction
spellingShingle Pattiya Pila
Phongsakorn Chuammitri
Phongsakorn Chuammitri
Prapas Patchanee
Kidsadagon Pringproa
Kakanang Piyarungsri
Kakanang Piyarungsri
Evaluation of Bcl-2 as a marker for chronic kidney disease prediction in cats
Frontiers in Veterinary Science
Bcl-2
biomarker
cat
chronic kidney disease
prediction
title Evaluation of Bcl-2 as a marker for chronic kidney disease prediction in cats
title_full Evaluation of Bcl-2 as a marker for chronic kidney disease prediction in cats
title_fullStr Evaluation of Bcl-2 as a marker for chronic kidney disease prediction in cats
title_full_unstemmed Evaluation of Bcl-2 as a marker for chronic kidney disease prediction in cats
title_short Evaluation of Bcl-2 as a marker for chronic kidney disease prediction in cats
title_sort evaluation of bcl 2 as a marker for chronic kidney disease prediction in cats
topic Bcl-2
biomarker
cat
chronic kidney disease
prediction
url https://www.frontiersin.org/articles/10.3389/fvets.2022.1043848/full
work_keys_str_mv AT pattiyapila evaluationofbcl2asamarkerforchronickidneydiseasepredictionincats
AT phongsakornchuammitri evaluationofbcl2asamarkerforchronickidneydiseasepredictionincats
AT phongsakornchuammitri evaluationofbcl2asamarkerforchronickidneydiseasepredictionincats
AT prapaspatchanee evaluationofbcl2asamarkerforchronickidneydiseasepredictionincats
AT kidsadagonpringproa evaluationofbcl2asamarkerforchronickidneydiseasepredictionincats
AT kakanangpiyarungsri evaluationofbcl2asamarkerforchronickidneydiseasepredictionincats
AT kakanangpiyarungsri evaluationofbcl2asamarkerforchronickidneydiseasepredictionincats